Reuters · 25 Sep, 07:59 · Technology briefing

Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology

Nanexa, a specialist in microfluidics and injection technology, has seen its share price surge following a landmark €1.17 billion agreement with pharmaceutical giant Novo Nordisk.

What it means for you ↓ Courses for this story

30%premium for professionals who pair domain skills with tech fluency

3.5xfaster skill turnover — staying current is the moat

74%of employers fund staff who self-start upskilling

20days to your first credential

The briefing

The story
in brief.

What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.

Nanexa, a specialist in microfluidics and injection technology, has seen its share price surge following a landmark €1.17 billion agreement with pharmaceutical giant Novo Nordisk. The deal centres on licensing advanced injection systems, likely supporting the delivery of Novo Nordisk’s high-demand weight-loss and diabetes medications. This transaction underscores the critical role of specialised medical device engineering in the broader pharmaceutical supply chain. For professionals, it highlights the growing commercial value of niche technological partnerships within the healthcare sector, demonstrating how precision engineering firms can secure substantial revenue streams by integrating with major drug manufacturers.

Employer demand for Healthcare Management skills — indexed growth since 2019
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)

Your move

What this means
for your career.

Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.

This development signals a significant shift in value towards specialised medical device engineering and strategic partnership management. If you work in healthcare or life sciences, you must now prioritise understanding the intersection of drug delivery mechanisms and commercial scaling. Skills in regulatory compliance, cross-functional project management, and technical licensing are becoming premium assets. You should actively seek roles that bridge engineering and commercial strategy, particularly within biotech or medical device sectors. Focus on mastering the nuances of intellectual property valuation and supply chain integration for medical technologies. Professionals who can articulate the commercial viability of niche hardware solutions will find themselves in high demand. Start networking with firms specialising in microfluidics or injection systems to understand their operational models and career pathways.

For this story, the fields that convert it into pay are Healthcare Management, Project Management, Compliance And Governance and Innovation — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.

Indicative salary uplift in the fields matched to this story
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below

Matched to this story

Enrol in these
to benefit.

These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.